185 related articles for article (PubMed ID: 36437244)
1. Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres.
Maciejewska N; Olszewski M; Jurasz J; Baginski M; Stasevych M; Zvarych V; Folini M; Zaffaroni N
Cell Death Dis; 2022 Nov; 13(11):1005. PubMed ID: 36437244
[TBL] [Abstract][Full Text] [Related]
2. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
3. The Insertion in Fingers Domain in Human Telomerase Can Mediate Enzyme Processivity and Telomerase Recruitment to Telomeres in a TPP1-Dependent Manner.
Chu TW; D'Souza Y; Autexier C
Mol Cell Biol; 2016 Jan; 36(1):210-22. PubMed ID: 26503784
[TBL] [Abstract][Full Text] [Related]
4. Telomerase inhibitors induce mitochondrial oxidation and DNA damage-dependent cell death rescued by Bcl-2/Bcl-xL.
Jayaprasad AG; Chandrasekharan A; Arun Jyothi SP; John Sam SM; Santhoshkumar TR; Pillai MR
Int J Biol Macromol; 2024 Apr; 264(Pt 1):130151. PubMed ID: 38403227
[TBL] [Abstract][Full Text] [Related]
5. Telomerase reverse transcriptase expression protects transformed human cells against DNA-damaging agents, and increases tolerance to chromosomal instability.
Fleisig HB; Hukezalie KR; Thompson CA; Au-Yeung TT; Ludlow AT; Zhao CR; Wong JM
Oncogene; 2016 Jan; 35(2):218-27. PubMed ID: 25893297
[TBL] [Abstract][Full Text] [Related]
6. Induction of senescence in cancer cells by the G-quadruplex stabilizer, BMVC4, is independent of its telomerase inhibitory activity.
Huang FC; Chang CC; Wang JM; Chang TC; Lin JJ
Br J Pharmacol; 2012 Sep; 167(2):393-406. PubMed ID: 22509942
[TBL] [Abstract][Full Text] [Related]
7. G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells.
Amato R; Valenzuela M; Berardinelli F; Salvati E; Maresca C; Leone S; Antoccia A; Sgura A
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32183119
[TBL] [Abstract][Full Text] [Related]
8. Targeting DNA-PKcs and telomerase in brain tumour cells.
Gurung RL; Lim HK; Venkatesan S; Lee PS; Hande MP
Mol Cancer; 2014 Oct; 13():232. PubMed ID: 25307264
[TBL] [Abstract][Full Text] [Related]
9. p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells.
Jones KR; Elmore LW; Jackson-Cook C; Demasters G; Povirk LF; Holt SE; Gewirtz DA
Int J Radiat Biol; 2005 Jun; 81(6):445-58. PubMed ID: 16308915
[TBL] [Abstract][Full Text] [Related]
10. Low p16
Graham MK; Principessa L; Antony L; Meeker AK; Isaacs JT
Prostate; 2017 Mar; 77(4):374-384. PubMed ID: 27859428
[TBL] [Abstract][Full Text] [Related]
11. Telomere shortening and cell senescence induced by perylene derivatives in A549 human lung cancer cells.
Taka T; Huang L; Wongnoppavich A; Tam-Chang SW; Lee TR; Tuntiwechapikul W
Bioorg Med Chem; 2013 Feb; 21(4):883-90. PubMed ID: 23321015
[TBL] [Abstract][Full Text] [Related]
12. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function.
Burger AM; Dai F; Schultes CM; Reszka AP; Moore MJ; Double JA; Neidle S
Cancer Res; 2005 Feb; 65(4):1489-96. PubMed ID: 15735037
[TBL] [Abstract][Full Text] [Related]
13. NSC746364, a G-quadruplex-stabilizing agent, suppresses cell growth of A549 human lung cancer cells through activation of the ATR/Chk1-dependent pathway.
Chung YL; Pan CH; Liou WH; Sheu MJ; Lin WH; Chen TC; Huang HS; Wu CH
J Pharmacol Sci; 2014; 124(1):7-17. PubMed ID: 24441772
[TBL] [Abstract][Full Text] [Related]
14. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
Babizhayev MA; Yegorov YE
J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
[TBL] [Abstract][Full Text] [Related]
15. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
16. Activation of human telomerase reverse transcriptase expression by some new symmetrical bis-substituted derivatives of the anthraquinone.
Huang HS; Chiou JF; Fong Y; Hou CC; Lu YC; Wang JY; Shih JW; Pan YR; Lin JJ
J Med Chem; 2003 Jul; 46(15):3300-7. PubMed ID: 12852760
[TBL] [Abstract][Full Text] [Related]
17. Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells.
Celeghin A; Giunco S; Freguja R; Zangrossi M; Nalio S; Dolcetti R; De Rossi A
Cell Death Dis; 2016 Dec; 7(12):e2562. PubMed ID: 28032863
[TBL] [Abstract][Full Text] [Related]
18. Treating Cancer by Targeting Telomeres and Telomerase.
Ivancich M; Schrank Z; Wojdyla L; Leviskas B; Kuckovic A; Sanjali A; Puri N
Antioxidants (Basel); 2017 Feb; 6(1):. PubMed ID: 28218725
[TBL] [Abstract][Full Text] [Related]
19. Development of highly predictive 3D-QSAR CoMSIA models for anthraquinone and acridone derivatives as telomerase inhibitors targeting G-quadruplex DNA telomere.
Zambre VP; Murumkar PR; Giridhar R; Yadav MR
J Mol Graph Model; 2010 Sep; 29(2):229-39. PubMed ID: 20691626
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives.
Huang HS; Huang KF; Li CL; Huang YY; Chiang YH; Huang FC; Lin JJ
Bioorg Med Chem; 2008 Jul; 16(14):6976-86. PubMed ID: 18571928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
